La. Admin. Code tit. 33 § XV-417

Current through Register Vol. 50, No. 9, September 20, 2024
Section XV-417 - Dose to an Embryo/Fetus
A. The licensee or registrant shall ensure that the dose equivalent to the embryo/fetus during the entire pregnancy, due to occupational exposure of a declared pregnant woman, does not exceed 5 mSv (0.5 rem). See LAC 33:XV.476 for recordkeeping requirements.
B. The licensee or registrant shall make efforts to avoid substantial variation2 above a uniform monthly exposure rate to a declared pregnant woman so as to satisfy the limit in Subsection A of this Section.
C. The dose equivalent to the embryo/fetus is the sum of:
1. the deep-dose equivalent to the declared pregnant woman; and
2. the dose equivalent to the embryo/fetus resulting from radionuclides in the embryo/fetus and radionuclides in the declared pregnant woman.
D. If by the time the woman declares pregnancy to the licensee or registrant, the dose equivalent to the embryo/fetus has exceeded 5 mSv (0.5 rem), the licensee or registrant shall be deemed to be in compliance with Subsection A of this Section if the additional dose equivalent to the embryo/fetus does not exceed 0.5 mSv (0.05 rem) during the remainder of the pregnancy.2

2 The National Council on Radiation Protection and Measurements recommended in NCRP Report No. 91, "Recommendations on Limits for Exposure to Ionizing Radiation" (June 1, 1987), that no more than 0.5 mSv (0.05 rem) to the embryo/fetus be received in any one month.

La. Admin. Code tit. 33, § XV-417

Promulgated by the Department of Environmental Quality, Nuclear Energy Division, LR 13:569 (October 1987), amended by the Office of Air Quality and Radiation Protection, Radiation Protection Division, LR 19:1421 (November 1993), LR 22:970 (October 1996), amended by the Office of Environmental Assessment, Environmental Planning Division, LR 26:2769 (December 2000), amended by the Office of the Secretary, Legal Division, LR 40:1341 (July 2014).
AUTHORITY NOTE: Promulgated in accordance with R.S. 30:2001 et seq., and 2104.B.(1).